NeuroClin is a long‑established leader in neurological research, with more than 25 years’ experience across Alzheimer’s, Dementia, Memory Impairment and a growing range of neurological and mental health conditions. Operating from state‑of‑the‑art facilities in Eurocentral and Warrington, the organisation is recognised for its expertise in early detection, diagnosis and the delivery of innovative, clinically proven treatments.
Alongside its established research activity, NeuroClin launched a new Private Testing, Diagnosis & Treatment service in 2025, strengthening its ability to support patients with emerging disease‑modifying therapies not yet available in the NHS. Backed by experienced private equity partners, the business is now entering a significant phase of expansion.
The core purpose of this role is to lead the Financial Planning and Analysis (FP&A) function within a dynamic and evolving healthcare organisation. This position will be instrumental in driving the company’s growth strategy as it expands beyond its core clinical research operations into new therapeutic areas, geographies and service lines – including private treatment offerings. The successful candidate will provide strategic financial leadership, guide investment decisions, and ensure long‑term financial sustainability across both the research and treatment divisions.
Strategic Financial Planning Lead integrated financial planning across clinical trials and private treatment services
Develop a multi‑year integrated financial model (P&L, BS, CF) by service line
Conduct scenario analysis for new service lines, including ROI and break‑even modelling
Support strategic projects such as clinic launches and trial site acquisitions
Align financial strategy with regulatory frameworks
Forecasting & Budgeting Lead the annual budgeting cycle and rolling forecast process for both divisions, ensuring alignment with operational priorities and securing their endorsement
Build and own a database of past contracts that underpin forecasting and support the creation of data‑rich marketing collateral
Monitor cost structures and build pricing strategy for research and private treatments
Provide insight and analysis including identification of risks and opportunities in the budgeting and forecasting process
Own and maintain the company risk register
Performance Reporting Deliver monthly MI packs with KPIs tailored to clinical research and treatment metrics
Provide variance analysis and commentary for the senior leadership team and board
Implement dashboards for real‑time operational and financial insights
Business Partnering Collaborate with Clinical Ops, Commercial, and Medical team to support financial decisions, ensuring they have access to accurate and value‑added operational data and insight
Build models to underpin commercial contracts and support legal in contract negotiations
Collaborate cross‑departmentally to identify areas where efficiency improvements in both profitability and working capital position can be made to drive performance, reduce cost, and enhance margins
Work with Business Development Manager to build robust pipeline KPI reporting which feeds into rolling forecasts. This role will work closely with the BD and Operations to support weekly BD accountability meetings
The successful candidate will bring substantial FP&A experience and a natural ability to connect Finance and Operations, demonstrating sound judgement in identifying and leveraging meaningful data to enhance operational insights. This role will work closely with the CFO and will at times deputise; therefore, a broad finance skillset and the ability to build effective, collaborative relationships will be essential. The role will also offer exposure to the Board.
For more information on this role, please contact Hazel Wynn at Rutherford Cross: hazelwynn@rutherfordcross.com
#J-18808-Ljbffr